Literature DB >> 15832139

Accuracy of intramuscular injection of botulinum toxin A in juvenile cerebral palsy: a comparison between manual needle placement and placement guided by electrical stimulation.

Terence Y P Chin1, Gary R Nattrass, Paulo Selber, H Kerr Graham.   

Abstract

Most clinicians who perform botulinum toxin A injections for children with cerebral palsy do so using the "free-hand" or manual technique without using radiologic or electrophysiologic guidance to aid needle placement. The objective of this study was to investigate the accuracy of manual needle placement compared with needle placement guided by electrical stimulation. A total of 1,372 separate injections for upper and lower limb spasticity were evaluated in 226 children with cerebral palsy. The accuracy of manual needle placement compared with electrical stimulation was acceptable only for gastroc-soleus (>75%); it was unacceptable for the hip adductors (67%), medial hamstrings (46%), tibialis posterior (11%), biceps brachii (62%), and forearm and hand muscles (13% to 35%). The authors recommend using electrical stimulation or other guidance techniques to aid accurate needle placement in all muscles except the gastroc-soleus. Further study is needed to determine whether more accurate injecting will lead to better functional outcomes and more efficient use of botulinum toxin A.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15832139     DOI: 10.1097/01.bpo.0000150819.72608.86

Source DB:  PubMed          Journal:  J Pediatr Orthop        ISSN: 0271-6798            Impact factor:   2.324


  25 in total

1.  Botulinum Toxin in the Treatment of Pediatric Upper Limb Spasticity.

Authors:  Aloysia L Schwabe
Journal:  Semin Plast Surg       Date:  2016-02       Impact factor: 2.314

2.  Muscle fiber orientation in muscles commonly injected with botulinum toxin: an anatomical pilot study.

Authors:  S Deshpande; M E Gormley; J R Carey
Journal:  Neurotox Res       Date:  2006-04       Impact factor: 3.911

Review 3.  Botulinum toxin treatment of children with cerebral palsy - a short review of different injection techniques.

Authors:  A S Schroeder; S Berweck; S H Lee; F Heinen
Journal:  Neurotox Res       Date:  2006-04       Impact factor: 3.911

4.  Comparison of surface and ultrasound localization to identify forearm flexor muscles for botulinum toxin injections.

Authors:  M Kristi Henzel; Michael C Munin; Christian Niyonkuru; Elizabeth R Skidmore; Douglas J Weber; Ross D Zafonte
Journal:  PM R       Date:  2010-07       Impact factor: 2.298

Review 5.  Use of botulinum toxin A in adult neurological disorders: efficacy, tolerability and safety.

Authors:  Wilhelm J Schulte-Mattler
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

6.  High dose botulinum toxin A for the treatment of lower extremity hypertonicity in children with cerebral palsy.

Authors:  Allison W Willis; Beth Crowner; Janice E Brunstrom; Abigail Kissel; Brad A Racette
Journal:  Dev Med Child Neurol       Date:  2007-11       Impact factor: 5.449

Review 7.  Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral palsy (UPDATE).

Authors:  Brian J Hoare; Margaret A Wallen; Christine Imms; Elmer Villanueva; Hyam Barry Rawicki; Leeanne Carey
Journal:  Cochrane Database Syst Rev       Date:  2010-01-20

Review 8.  Nonoperative management of spasticity in children.

Authors:  Susan Ronan; Joan T Gold
Journal:  Childs Nerv Syst       Date:  2007-07-24       Impact factor: 1.475

9.  Adductor release and chemodenervation in children with cerebral palsy: a pilot study in 16 children.

Authors:  Abhay Khot; Samuel Sloan; Sameer Desai; Adrienne Harvey; Rory Wolfe; H Kerr Graham
Journal:  J Child Orthop       Date:  2008-06-07       Impact factor: 1.548

10.  Effectiveness of resistance training in combination with botulinum toxin-A on hand and arm use in children with cerebral palsy: a pre-post intervention study.

Authors:  Ann-Kristin G Elvrum; Siri M Brændvik; Rannei Sæther; Torarin Lamvik; Beatrix Vereijken; Karin Roeleveld
Journal:  BMC Pediatr       Date:  2012-07-02       Impact factor: 2.125

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.